- Home
- ESEA vs JSPR Comparison
ESEA vs JSPR Comparison
Compare ESEA & JSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ESEA | JSPR |
|---|---|---|
| Founded | 2005 | 2018 |
| Country | Greece | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 389.3M | 43.7M |
| IPO Year | 2005 | N/A |
Fundamental Metrics
Financial Performance| Metric | ESEA | JSPR |
|---|---|---|
| Price | $66.05 | $1.23 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 10 |
| Target Price | ★ $62.00 | $18.13 |
| AVG Volume (30 Days) | 62.7K | ★ 303.8K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 4.76% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $1.49 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $3.39 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $26.30 | $1.11 |
| 52 Week High | $72.87 | $7.19 |
Technical Indicators
Market Signals| Indicator | ESEA | JSPR |
|---|---|---|
| Relative Strength Index (RSI) | 56.97 | 38.99 |
| Support Level | $51.63 | $1.11 |
| Resistance Level | $72.87 | $1.44 |
| Average True Range (ATR) | 3.72 | 0.08 |
| MACD | -0.42 | -0.01 |
| Stochastic Oscillator | 48.57 | 19.64 |
Price Performance
Historical ComparisonAbout ESEA Euroseas Ltd. (Marshall Islands)
Euroseas Ltd is a shipping company. Its fleet consists of containerships that transport container boxes, providing scheduled service between ports. Its operations are managed by an affiliated ship management company, which is responsible for the day-to-day commercial and technical management and operations of the vessels. The company employs its vessels on spot and period charters and through pool arrangements.
About JSPR Jasper Therapeutics Inc.
Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.